Developments in the treatment of carcinoid syndrome – impact of telotristat
David L Chan, Simron Singh Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Abstract: Carcinoid syndrome occurs in 20% of patients with neuroendocrine tumors, and serotonin is usually the main causative hormonal peptide. Carcinoid syndrome, and particularly diarrhea, can...
Saved in:
Main Authors: | Chan DL (Author), Singh S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The journey from gene knockout to clinical medicine: telotristat and sotagliflozin
by: Rendell MS
Published: (2019) -
Endobronchial Carcinoid and Concurrent Carcinoid Syndrome in an Adolescent Female
by: Jonathan D. Cogen, et al.
Published: (2016) -
Síndrome carcinóide: relato de caso Carcinoid syndrome: case report
by: Ane Beatriz Mautari Niwa, et al.
Published: (2008) -
Simultaneous surgical treatment of primary ovarian carcinoid and carcinoid heart disease
by: Uladzimir Andrushchuk, et al.
Published: (2022) -
Anesthetic management of patients with carcinoid syndrome and carcinoid heart disease: A systematic review
by: José Luis Iglesias-González, et al.
Published: (2022)